共 195 条
[1]
Gerich JE(2010)Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications Diabet Med 27 136-142
[2]
Rahmoune H(2005)Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes Diabetes 54 3427-3434
[3]
Thompson PW(2014)Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia Am J Physiol Renal Physiol 306 F188-F193
[4]
Ward JM(2015)Sodium-glucose linked transporter 2 (SGLT2) inhibitors in the management of type-2 diabetes: a drug class overview Pharm Ther 40 451-462
[5]
Smith CD(2013)Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitus J Diabetes Complic 27 268-273
[6]
Hong G(2014)Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus J Diabetes Investig 5 382-391
[7]
Brown J(2018)A phase 3 randomized placebo-controlled trial to assess the efficacy and safety of ipragliflozin as an add-on therapy to metformin in Russian patients with inadequately controlled type 2 diabetes mellitus Diabetes Res Clin Pract 146 240-250
[8]
Rieg T(2015)A randomized, double-blind, placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the Long-Term ASP1941 Safety Evaluation in Patients with Type 2 Diabetes Diabetes Obes Metab 17 152-160
[9]
Masuda T(2015)Ipragliflozin improves glycemic control in Japanese patients with type 2 diabetes mellitus: the BRIGHTEN study Diabetol Int 6 8-18
[10]
Gerasimova M(2013)Efficacy and safety of ipragliflozin in patients with type 2 diabetes inadequately controlled on metformin: a dose-finding study Diabetes Obes Metab 15 403-409